semaglutide market Report: Size, Growth, Trends & Forecast (2025–2033) semaglutide revenue Semaglutide Market Size,
Description
The STEP 1 trial (published in the New England Journal of Medicine) documented mean weight reductions of 14.9% with once-weekly semaglutide 2.4 mg compared to 2.4% with placebo, with corresponding improvements in waist circumference of approximately 13.5 cm with semaglutide versus 4.1 cm with placebo after 68 weeks
Any haze, film, or floating specks indicates incomplete dissolution
Same day, roughly same time, every week, without exception
Weight loss typically reaches 15 to 20% during this window, producing mechanical benefits for breathing and sleep positioning
